Skip to main content
Caplight Logo









Datexim

Datexim

Private
CaenHealthcare & Life Scienceshttps://datexim.ai/

Last Round

VC Round

Oct 1, 2020

Total Funding Raised

$1.68M

Company Overview

Datexim is a healthcare technology company that develops AI-powered digital pathology solutions for cervical cancer screening and diagnostic workflow optimization.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologymedical AIautomated cytologyhistology analysiscomputer visionpathology softwareAI diagnosticspathology AIclinical workflow automationmedical imagingSaaS health-techcomputational pathologydiagnostic softwarelab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Datexim Comparables

Compare Datexim with similar companies based on industry and business-model similarity.

Datexim comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MindPeak
86%
Primaa
82%
Tribun Health
81%

Datexim Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 1, 2020
Series AMay 1, 2019

Key People

Founding team and executive leadership

Vianney Thurotte

Chief Technology Officer

Executive Team

Datexim Investors

Notable investors and investment history

Datexim investors
InvestorRounds
Odyssée VentureSeries A, VC Round
Normandie ParticipationsSeries A, Seed
BpifranceSeed
Normandie Business AngelsSeed
Région NormandieSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors grew 88% MoM, from 631 to 1.2K.

  • Oct 1, 2020

    $1.18M round led by Odyssée Venture

Datexim Filings

Explore SEC and related filing metadata, where available.

Datexim filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Datexim's valuation, stock price, and market status.

Is Datexim a public or private company?

Datexim is a private company.

What is the current stock price of Datexim?

Datexim is a private company with no public stock price. No recent secondary market data is available.

How much is Datexim worth (valuation)?

Valuation information for Datexim is not publicly available.

Can I buy Datexim stock?

Datexim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Datexim's last funding round?

Datexim's most recent funding round was VC Round on October 1, 2020.

Who are the main investors in Datexim?

Key investors in Datexim include Odyssée Venture.

Will Datexim IPO soon?

No public IPO plans have been announced for Datexim.

How can I track Datexim secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Datexim's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCaen
Employee Range13
Year Founded2011
Last FundingOct 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?